Drawing for ARTIVION

USPTO serial 90981072

ARTIVION

Reviewed by CopyMark Law Group

Reg. 7489375Status 700Registered
Filing date
Status date
Registration date
Aug 27, 2024
Examiner
MOLINOFF, JEFFREY S.
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ARTIVION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Durkee

Christopher M. Durkee QUICKER LAW, LLCSuite 100900 Circle 75 ParkwayATLANTA, GA 30339

Goods and services

ClassDescriptionStatusFirst use
005Surgical implants and grafts comprising cardiac and vascular biological tissue; biological adhesives for surgical and clinical use, namely, surgical glue; absorbable hemostats for surgical and clinical use; surgical glueACTIVEFeb 9, 2024
010Medical devices, namely implantable medical devices for treatment of cardiac, vascular, and aortic diseases, namely, prosthetic heart valves, aortic stents and stent grafts; cardiac lasers for medical use; surgical apparatuses and instruments; surgical implants comprised of artificial materials; prosthetic heart valves; applicators, dispensers, and spreader tips for biological adhesives for medical use; applicators, dispensers, and spreader tips for absorbable hemostats for medical useACTIVEJan 5, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 27, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 18, 2024ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jul 15, 2024SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 15, 2024CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 11, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 11, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 11, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 10, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 10, 2024DPCCDIVISIONAL PROCESSING COMPLETE—
Jun 10, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 1, 2024IUAFUSE AMENDMENT FILED—
May 1, 2024DRRRDIVISIONAL REQUEST RECEIVED—
May 1, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 1, 2024ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Nov 2, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 31, 2023EX2GSOU EXTENSION 2 GRANTED—
Oct 31, 2023EXT2SOU EXTENSION 2 FILED—
Oct 31, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 24, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 24, 2023NOACCORRECTED NOA E-MAILED—
May 23, 2023EX1GSOU EXTENSION 1 GRANTED—
May 23, 2023DPCCDIVISIONAL PROCESSING COMPLETE—
May 23, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 28, 2023EXT1SOU EXTENSION 1 FILED—
Apr 28, 2023DRRRDIVISIONAL REQUEST RECEIVED—
Apr 28, 2023ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Apr 28, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 1, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 18, 2022ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jun 23, 2022ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 8, 2022ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 16, 2022LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN—
May 16, 2022LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
May 10, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 10, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 20, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 7, 2022CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Apr 4, 2022APETASSIGNED TO PETITION STAFF—
Mar 29, 2022PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 25, 2022EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Mar 16, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 16, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Mar 16, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 16, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 16, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 11, 2022DOCKASSIGNED TO EXAMINER—
Sep 5, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 24, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance